Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C006780 |
bisphenol A |
bisphenol A results in increased expression of ASMTL mRNA | increases expression | 20678512
|
D002330 |
Carmustine |
Carmustine results in decreased expression of ASMTL mRNA | decreases expression | 15980968
|
C014347 |
decitabine |
[decitabine co-treated with vorinostat] affects the expression of ASMTL mRNA | affects cotreatment|affects expression | 17330099
|
D008767 |
Methylmercury Compounds |
Methylmercury Compounds results in decreased expression of ASMTL protein | decreases expression | 18959786
|
D012402 |
Rotenone |
Rotenone results in increased expression of ASMTL mRNA | increases expression | 19013527
|
D012643 |
Selenium |
Selenium results in increased expression of ASMTL mRNA | increases expression | 19244175
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of ASMTL mRNA | increases expression | 19101580
|
C111237 |
vorinostat |
[decitabine co-treated with vorinostat] affects the expression of ASMTL mRNA | affects cotreatment|affects expression | 17330099
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
3.82 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.17 | 19490988 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.61 | 17688650 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.76 | 17497229 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.99 | 18177632 17507914 18396377 18316065 18940202 18558336 16609825 18985861 18775368 17157402 15238991 17688650 19232924 19460635 20603192 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.18 | 20046352 17594078 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.54 | 8888407 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
4.10 | 11985600 |
MESH:D001932 |
Brain Neoplasms |
|
Carmustine |
4.61 | 16187019 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
2.15 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
2.15 | 18320071 19208741 |
MESH:D001943 |
Breast Neoplasms |
|
vorinostat |
2.15 | 16144943 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
5.33 | 17123778 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
2.65 | 19215824 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.78 | 20734317 |
MESH:D003092 |
Colitis |
|
Selenium |
4.09 | 17936198 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
2.37 | 17616700 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.10 | 18981723 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
1.90 | 17688650 16575769 8888407 |
MESH:D003704 |
Dementia |
|
Methylmercury Compounds |
5.24 | 16140633 |
MESH:D003967 |
Diarrhea |
|
vorinostat |
4.77 | 20479100 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
4.20 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
4.20 | 19641884 1733752 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.31 | 1851702 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
5.49 | 19294695 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.46 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.29 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
3.04 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.80 | 6426943 7562514 6254150 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.60 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.40 | 3659116 |
MESH:D005221 |
Fatigue |
|
vorinostat |
5.93 | 20479100 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
3.54 | 14986274 19224547 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.26 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.41 | 18558336 8888407 |
MESH:D005909 |
Glioblastoma |
|
Carmustine |
4.07 | 16187019 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
3.64 | 19215824 |
MESH:D006333 |
Heart Failure |
|
Selenium |
3.21 | 17162251 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.20 | 17688650 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
3.35 | 17581917 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
4.57 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
3.44 | 16393666 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
4.13 | 16518626 |
MESH:D007938 |
Leukemia |
|
decitabine |
3.18 | 19235587 18980019 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
4.24 | 19117987 18454857 17236224 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
marker/mechanism |
|
| 17330099 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
4.12 | 18704418 18206229 18460780 19387464 17679729 19010910 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
4.12 | 16294345 17596541 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.84 | 18055864 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.64 | 17228818 |
MESH:D008223 |
Lymphoma |
|
decitabine |
3.58 | 19470736 |
MESH:D016410 |
Lymphoma, T-Cell, Cutaneous |
|
vorinostat |
5.99 | 20479100 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
2.90 | 15318939 |
MESH:D008545 |
Melanoma |
|
Carmustine |
3.87 | 12393984 |
MESH:D008545 |
Melanoma |
|
decitabine |
3.87 | 16505122 17785578 |
MESH:D008569 |
Memory Disorders |
|
Methylmercury Compounds |
5.19 | 18436314 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
2.87 | 15107826 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.36 | 18803445 18765137 |
MESH:D009069 |
Movement Disorders |
|
Methylmercury Compounds |
5.59 | 18436314 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
3.51 | 18172295 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.27 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
7.92 | 19157545 16882708 19010910 18608210 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
7.92 | 17596541 |
MESH:D009325 |
Nausea |
|
vorinostat |
5.90 | 20479100 |
MESH:D009369 |
Neoplasms |
|
decitabine |
2.81 | 19470736 19116145 17925555 |
MESH:D009410 |
Nerve Degeneration |
|
Rotenone |
4.06 | 17356569 15790535 18619942 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
4.25 | 11399458 16427766 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.27 | 8888407 16359493 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
5.33 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
2.71 | 19331143 19259094 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
2.84 | 19294695 |
MESH:D010300 |
Parkinson Disease |
|
Rotenone |
3.05 | 16140633 18619942 18191903 16412576 15451049 19232380 19114014 11445065 11535288 |
MESH:D020734 |
Parkinsonian Disorders |
|
Rotenone |
4.30 | 15574749 18197244 15927086 15795934 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
5.27 | 15087411 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
18.57 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Methylmercury Compounds |
18.57 | 18436314 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
18.57 | 20603192 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
5.03 | 17616702 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
4.45 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
3.72 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
vorinostat |
3.72 | 17218635 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.92 | 12752131 11422049 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
5.12 | 10548101 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
11.86 | 19155313 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
11.86 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.09 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.89 | 16876388 15475178 14763951 11738929 17978042 11044598 3137016 1511512 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.96 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.92 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
2.10 | 19037991 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
4.32 | 16684133 16045194 |
MESH:D013921 |
Thrombocytopenia |
|
vorinostat |
5.20 | 20479100 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
3.51 | 17967635 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.61 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.86 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
2.80 | 17616700 19087683 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.95 | 8888407 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
5.38 | 14652134 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
5.29 | 17785578 |